$1.42
Open
-$0.13(-8.06%)

Today

About

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 987 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Country

US

CEO

Ms. Suzanne Winter

IPO date

2007

Employees

987

ISIN

US0043971052

Key stats

Open

$2.00

Volume

1.02M

Market cap

$159.39M

Prev. close

$1.55

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$1.40

52W Range

$2.95

Valuation

28
Valuation score
Overvalued
P/E
-
P/S
0.44
P/B
4.16
Current ratio
1.62
Debt / Equity
2.36
ROE
-9.75%
Gross margin
36.06%
Income growth
-164.16%
FCF growth
-111.02

Analysts estimates

Consensus rating
Buy

The average rating from top 10 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$6.25
The top 6 analysts forecasts that 12-month price may increase by 339.96%, with a low of $5.56 and a high of $7.35
$5.56
Low
$6.25
Avg
$7.35
High
Current price

Earnings

Q4 ‘24 revenue
$116.17M
Q4 ‘24 net income
$2.54M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.00
Actual EPS
Estimate EPS